Effectiveness of sustained-release bupropion in the treatment of smoker patients with cardiovascular disease;Efetividade da bupropiona no tratamento de pacientes tabagistas com doença cardiovascular

Arquivos Brasileiros de Cardiologia

Volumn 88, Issue 4, 2007, Pages

  Issa, Jaqueline Scholz ^a,b   Perez, Glória Heloise ^a   Diament, Jayme ^a   Zavattieri, Angela Giuliana ^a   De Oliveira, Kátia Ulrich ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Bupropion; Cardiovascular diseases; Smoking treatment

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; ANTIDEPRESSANT AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANGIONEUROTIC EDEMA; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PREDICTOR VARIABLE; QUESTIONNAIRE; RASH; SEX RATIO; SIDE EFFECT; SMOKING; SMOKING CESSATION; STATE TRAIT ANXIETY INVENTORY; SUSTAINED DRUG RELEASE; TOBACCO DEPENDENCE; TREATMENT DURATION; XEROSTOMIA; DELAYED RELEASE FORMULATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CARDIOVASCULAR DISEASES; DELAYED-ACTION PREPARATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 34250028223     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wilson K, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction. Arch Intern Med. 2000; 160: 939-44.
2. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999; 340: 685-91.
3. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997; 227: 1195-202.
4. Treating tobacco use and dependence - Clinical practice guideline. U.S. Department of Health and Human Services; 2000.
5. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991; 86: 1119-27.
6. Beck AT, Steer RA. Beck Depression Inventory Manual. Toronto, Canada: Psychological Corp. Harcourt, Brace, Jovanovich; 1987.
7. Gorenstein C, Andrade L. Inventário de depressão de Beck: propriedades psicométricas da versão em português. Rev Psiq Clin. 1998; 25 (5): 245-50 (edição especial).
8. Spielberger CD, Gersuch RL, Lushene RE. Inventário de ansiedade traço-estado (State-Trait Anxiety Inventory - STAI). Rio de Janeiro: Ed. CEPA; 1979.
9. Spielberger CD. Anxiety: state-trait process. In: Spielberger CD, Sarason IG, editors. Stress and anxiety. USA: Hemisphere Publishing Corporation; 1975.
10. Babor TF, Grant M. From clinical research to secondary prevention: international collaboration in the development of the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Health Res World. 1989; 13: 371-4.
11. Figlie NB, Pillon SC, Laranjeira RR, Dunn J. O AUDIT identifica a necessidade de interconsulta específica para dependentes de álcool no Hospital Geral? J Bras Psiquiatr. 1997; 46 (11): 589-93.
12. Johnston JA, Fiedler-Kelly J, Glover ED, Sachs DF, Grasela TH, De Veaugh-Geiss J. Relationship between drug exposure and the efficacy and safety of bupropion sustained-release for smoking cessation. Nicotine Tob Res. 2001; 3: 131-40.
13. Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med. 2004; 19: 893-5.
14. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation and major depressions. JAMA. 1990; 264: 1546-9.
15. Issa JS, Giannini SD, Forti N, Diament J. Intervenção sobre o tabagismo realizado pelo cardiologista em rotina ambulatorial. Arq Bras Cardiol. 1998; 70: 271-4.
16. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, et al. Sustained-release bupropion of pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Intern Med. 2001; 135: 423-33.
17. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent events after myocardial infarction. Ann Intern Med. 2002; 137: 494-500.
18. Hajek P, Taylor T, Mills P. Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomised controlled trial. Br Med J. 2002; 324: 87-9.
19. Perkins KA. Smoking cessation in women: special considerations. CNS Drugs. 2001; 15 (5): 391-411.